Merck Wins Uk Okay For Keytruda In Lung Cancer After Price Cut
Britain’s healthcare cost-effectiveness watchdog NICE has recommended use of Merck’s immunotherapy drug Keytruda in certain lung cancer patients, after the…
Britain’s healthcare cost-effectiveness watchdog NICE has recommended use of Merck’s immunotherapy drug Keytruda in certain lung cancer patients, after the…